Přihlásit se Zaregistrujte se zdarma

Příjmy společnosti Nymox Pharmaceutical Corp

Jaká je hodnota metriky Příjmy společnosti Nymox Pharmaceutical Corp?

Hodnota metriky Příjmy společnosti Nymox Pharmaceutical Corp je -$8.05

Jaká je definice metriky Příjmy?

Výsledek příjmů pro kmenové akcionáře (Income) se rovná celkovému příjmu sníženému o přednostně vyplacené dividendy.

Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.

Příjmy společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Nymox Pharmaceutical Corp

Čemu se věnuje společnost Nymox Pharmaceutical Corp?

nymox pharmaceutical corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. its lead drug candidate is fexapotide triflutate (nx-1207) that has completed phase iii clinical trials for the treatment of benign prostatic hyperplasia; and is in phase ii clinical trial for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. the company also develops and markets nicalert and tobacalert test strips that use urine or saliva to detect use of tobacco products. in addition, it offers alzheimalert, a proprietary urine assay that aids physicians in the diagnosis of alzheimer's disease. the company operates in canada, the united states, europe, and internationally. nymox pharmaceutical corporation was founded in 1989 and is headquartered in nassau, bahamas.

Firmy s metrikou příjmy podobnou společnosti Nymox Pharmaceutical Corp